• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经导管三尖瓣修复术(TTVR)患者中 get with the guidelines-heart failure(GWTG-HF)风险评分的预后意义。

Prognostic significance of the get with the guidelines-heart failure (GWTG-HF) risk score in patients undergoing trans-catheter tricuspid valve repair (TTVR).

机构信息

Heart Center Bonn, Department of Medicine II, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.

出版信息

Heart Vessels. 2021 Dec;36(12):1903-1910. doi: 10.1007/s00380-021-01874-3. Epub 2021 May 22.

DOI:10.1007/s00380-021-01874-3
PMID:34023969
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8556194/
Abstract

The Get-With-The-Guidelines-Heart-Failure (GWTG-HF) score is a risk assessment tool to predict mortality in patients with heart-failure (HF). We aimed to evaluate the GWTG-HF score for risk stratification in HF patients with tricuspid regurgitation undergoing trans-catheter tricuspid valve repair (TTVR). In total, 181 patients who underwent TTVR via edge-to-edge repair (86%) or annuloplasty (14%) were enrolled. Patients were categorized into a low- (≤ 43 points), intermediate- (44-53 points) and high-risk score groups (≥ 54 points). TTVR led to an improvement of TR (p < 0.0001) and NYHA (p < 0.0001). Kaplan-Meier analysis and log-rank test revealed that higher GWTG-HF scores were associated with reduced rates of event-free survival regarding mortality (96% vs 89% vs 73%, respectively, p = 0.001) and hospitalization for heart failure (HHF) (89% vs 86% vs 74%, respectively, p = 0.026). After adjusting for important variables like renal function, left ventricular ejection fraction and mitral regurgitation, the GWTG-HF score remained an independent predictor of the composite endpoint of HHF or mortality (hazard ratio 1.04 per 1-point increase, p = 0.029). Other remaining predictors were renal function and mitral regurgitation. The GWTG-HF score used as a risk stratification tool of mortality and HHF maintains its prognostic value in a HF population with severe TR undergoing TTVR.

摘要

指南指导下的心衰(GWTG-HF)评分是一种预测心衰(HF)患者死亡率的风险评估工具。我们旨在评估 GWTG-HF 评分在心衰伴三尖瓣反流行经导管三尖瓣修复术(TTVR)患者中的风险分层作用。共有 181 例患者接受了缘对缘修复(86%)或瓣环成形术(14%)的 TTVR。患者被分为低危(≤43 分)、中危(44-53 分)和高危评分组(≥54 分)。TTVR 导致 TR(p<0.0001)和 NYHA(p<0.0001)改善。Kaplan-Meier 分析和对数秩检验显示,较高的 GWTG-HF 评分与死亡率(分别为 96%、89%和 73%,p=0.001)和心衰住院(HHF)(分别为 89%、86%和 74%,p=0.026)的无事件生存率降低相关。在调整肾功能、左心室射血分数和二尖瓣反流等重要变量后,GWTG-HF 评分仍然是 HHF 或死亡率复合终点的独立预测因素(每增加 1 分,风险比为 1.04,p=0.029)。其他剩余的预测因素是肾功能和二尖瓣反流。GWTG-HF 评分作为死亡率和 HHF 的风险分层工具,在心衰伴严重 TR 行经 TTVR 的患者中保持其预后价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd2/8556194/0ccdbeefa6be/380_2021_1874_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd2/8556194/d54e78b03ccc/380_2021_1874_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd2/8556194/0ccdbeefa6be/380_2021_1874_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd2/8556194/d54e78b03ccc/380_2021_1874_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd2/8556194/0ccdbeefa6be/380_2021_1874_Fig2_HTML.jpg

相似文献

1
Prognostic significance of the get with the guidelines-heart failure (GWTG-HF) risk score in patients undergoing trans-catheter tricuspid valve repair (TTVR).经导管三尖瓣修复术(TTVR)患者中 get with the guidelines-heart failure(GWTG-HF)风险评分的预后意义。
Heart Vessels. 2021 Dec;36(12):1903-1910. doi: 10.1007/s00380-021-01874-3. Epub 2021 May 22.
2
Transcatheter Edge-to-Edge Tricuspid Repair for Severe Tricuspid Regurgitation Reduces Hospitalizations for Heart Failure.经导管缘对缘三尖瓣修复术治疗重度三尖瓣反流可减少心力衰竭住院。
JACC Heart Fail. 2020 Apr;8(4):265-276. doi: 10.1016/j.jchf.2019.12.006.
3
Pulmonary capillary wedge pressure (PCWP) as prognostic indicator in patients undergoing transcatheter valve repair (TTVR) of severe tricuspid regurgitation.肺毛细血管楔压(PCWP)作为严重三尖瓣反流经导管瓣膜修复术(TTVR)患者的预后指标。
Int J Cardiol. 2020 Nov 1;318:32-38. doi: 10.1016/j.ijcard.2020.06.031. Epub 2020 Jun 27.
4
Predictors of Procedural and Clinical Outcomes in Patients With Symptomatic Tricuspid Regurgitation Undergoing Transcatheter Edge-to-Edge Repair.经导管缘对缘修复术治疗症状性三尖瓣反流患者的操作和临床结局的预测因素。
JACC Cardiovasc Interv. 2018 Jun 25;11(12):1119-1128. doi: 10.1016/j.jcin.2018.05.002.
5
Health Status After Transcatheter Tricuspid Valve Repair in Patients With Functional Tricuspid Regurgitation.功能性三尖瓣反流患者经导管三尖瓣修复术后的健康状况
JACC Cardiovasc Interv. 2021 Dec 13;14(23):2545-2556. doi: 10.1016/j.jcin.2021.09.021.
6
Transcatheter tricuspid valve repair in the setting of heart failure with preserved or reduced left ventricular ejection fraction.经导管三尖瓣修复术治疗射血分数保留或降低的心力衰竭。
Eur J Heart Fail. 2020 Oct;22(10):1817-1825. doi: 10.1002/ejhf.1975. Epub 2020 Sep 2.
7
Nutritional status in tricuspid regurgitation: implications of transcatheter repair.三尖瓣反流的营养状况:经导管修复的影响。
Eur J Heart Fail. 2020 Oct;22(10):1826-1836. doi: 10.1002/ejhf.1752. Epub 2020 Feb 26.
8
Clinical Characteristics and Outcomes of Patients Screened for Transcatheter Tricuspid Valve Replacement: The TriACT Registry.经筛选接受经导管三尖瓣置换术患者的临床特征和结局:TriACT 注册研究。
JACC Cardiovasc Interv. 2024 Feb 26;17(4):552-560. doi: 10.1016/j.jcin.2023.12.016.
9
Cardiopulmonary Hemodynamic Profile Predicts Mortality After Transcatheter Tricuspid Valve Repair in Chronic Heart Failure.慢性心力衰竭患者行经导管三尖瓣修复术后的心肺血流动力学特征预测死亡率。
JACC Cardiovasc Interv. 2021 Jan 11;14(1):29-38. doi: 10.1016/j.jcin.2020.09.033. Epub 2020 Dec 9.
10
Impact of Transcatheter Tricuspid Valve Repair for Severe Tricuspid Regurgitation on Kidney and Liver Function.经导管三尖瓣修复术治疗重度三尖瓣反流对肝肾功能的影响。
JACC Cardiovasc Interv. 2019 Aug 12;12(15):1413-1420. doi: 10.1016/j.jcin.2019.04.018. Epub 2019 May 21.

引用本文的文献

1
Prognostic Impact of the Get-with-the-Guidelines Heart-Failure Risk Score (GWTG-HF) after Transcatheter Aortic Valve Replacement in Patients with Low-Flow-Low-Gradient Aortic Valve Stenosis.低流量-低梯度主动脉瓣狭窄患者经导管主动脉瓣置换术后“遵循指南-心力衰竭风险评分”(GWTG-HF)的预后影响
Diagnostics (Basel). 2023 Apr 6;13(7):1357. doi: 10.3390/diagnostics13071357.
2
Prognostic impact of hepatorenal function in patients undergoing transcatheter tricuspid valve repair.经导管三尖瓣修复术患者肝肾功能对预后的影响。
Sci Rep. 2021 Jul 13;11(1):14420. doi: 10.1038/s41598-021-93952-9.

本文引用的文献

1
"Get with the Guidelines Heart Failure Risk Score" for mortality prediction in patients undergoing MitraClip.“Get with the Guidelines Heart Failure Risk Score”用于预测行经皮二尖瓣夹合术患者的死亡率。
Clin Res Cardiol. 2021 Dec;110(12):1871-1880. doi: 10.1007/s00392-021-01804-3. Epub 2021 Jan 31.
2
Pulmonary capillary wedge pressure (PCWP) as prognostic indicator in patients undergoing transcatheter valve repair (TTVR) of severe tricuspid regurgitation.肺毛细血管楔压(PCWP)作为严重三尖瓣反流经导管瓣膜修复术(TTVR)患者的预后指标。
Int J Cardiol. 2020 Nov 1;318:32-38. doi: 10.1016/j.ijcard.2020.06.031. Epub 2020 Jun 27.
3
Transcatheter Versus Medical Treatment of Patients With Symptomatic Severe Tricuspid Regurgitation.
经导管与药物治疗有症状的重度三尖瓣反流患者的效果比较。
J Am Coll Cardiol. 2019 Dec 17;74(24):2998-3008. doi: 10.1016/j.jacc.2019.09.028. Epub 2019 Sep 27.
4
6-Month Outcomes of Tricuspid Valve Reconstruction for Patients With Severe Tricuspid Regurgitation.三尖瓣重建治疗重度三尖瓣反流患者的 6 个月结果。
J Am Coll Cardiol. 2019 Apr 23;73(15):1905-1915. doi: 10.1016/j.jacc.2019.01.062.
5
Clinical Significance of Get With the Guidelines-Heart Failure Risk Score in Patients With Chronic Heart Failure After Hospitalization.住院慢性心力衰竭患者 Get With the Guidelines-Heart Failure 风险评分的临床意义。
J Am Heart Assoc. 2018 Sep 4;7(17):e008316. doi: 10.1161/JAHA.117.008316.
6
Six-month outcome after transcatheter edge-to-edge repair of severe tricuspid regurgitation in patients with heart failure.经导管缘对缘修复术治疗心力衰竭伴重度三尖瓣反流患者的 6 个月结局。
Eur J Heart Fail. 2018 Jun;20(6):1055-1062. doi: 10.1002/ejhf.1147. Epub 2018 Apr 26.
7
The need for a new tricuspid regurgitation grading scheme.对一种新的三尖瓣反流分级方案的需求。
Eur Heart J Cardiovasc Imaging. 2017 Dec 1;18(12):1342-1343. doi: 10.1093/ehjci/jex139.
8
Inpatient Mortality Risk Scores and Postdischarge Events in Hospitalized Heart Failure Patients: A Community-Based Study.住院心力衰竭患者的住院死亡率风险评分及出院后事件:一项基于社区的研究。
Circ Heart Fail. 2017 Jul;10(7). doi: 10.1161/CIRCHEARTFAILURE.117.003926.
9
Validation and Comparison of Seven Mortality Prediction Models for Hospitalized Patients With Acute Decompensated Heart Failure.七种急性失代偿性心力衰竭住院患者死亡率预测模型的验证与比较
Circ Heart Fail. 2016 Aug;9(8). doi: 10.1161/CIRCHEARTFAILURE.115.002912.
10
Validation of the Get With The Guideline-Heart Failure risk score in Japanese patients and the potential improvement of its discrimination ability by the inclusion of B-type natriuretic peptide level.日本患者中“遵循心力衰竭治疗指南风险评分”的验证以及通过纳入B型利钠肽水平对其鉴别能力的潜在改善。
Am Heart J. 2016 Jan;171(1):33-9. doi: 10.1016/j.ahj.2015.10.008. Epub 2015 Nov 11.